Botswana Vaccine Institute Disruptions Impact Regional Vaccine Supply
Production challenges at the Botswana Vaccine Institute (BVI) have reportedly led to significant financial ramifications for Botswana. The institute, a key supplier of Foot and Mouth Disease (FMD) vaccines, experienced interruptions that affected its ability to meet regional demand.
South Africa Seeks Alternative FMD Vaccine Sources
Facing a critical need for FMD vaccines, South Africa reportedly sought alternative suppliers. Due to the BVI’s production issues, South Africa turned to Argentina to secure the necessary vaccine doses.
Potential Export Revenue Losses for Botswana
This shift in vaccine sourcing may have resulted in millions of Pula in lost export earnings for Botswana. As a primary regional producer of FMD vaccines, any disruption in BVI’s operations can have substantial economic consequences for the nation.
Leave a Reply